Pharmacological and Endoscopic Interventions for Prophylaxis of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

被引:0
|
作者
Palomera-Tejeda, Emmanuel [1 ]
Shah, Mihir Prakash [1 ]
Attar, Bashar M. [2 ,3 ]
Shah, Hassam [2 ]
Sharma, Bharosa [1 ]
Oleas, Roberto [1 ]
Kotwal, Vikram [2 ,3 ]
Gandhi, Seema [2 ]
Mutneja, Hemant Raj [2 ,3 ]
机构
[1] John H Stroger Jr Hosp Cook Cty, Dept Internal Med, Chicago, IL 60612 USA
[2] John H Stroger Jr Hosp Cook Cty, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA
[3] Rush Univ, Div Gastroenterol & Hepatol, Med Ctr, Chicago, IL USA
关键词
Endoscopic retrograde cholangiopancreatography; Post-ERCP pancreatitis; Rectal NSAIDs; Pancreatic duct stenting; Chronic statin use; Chronic aspirin use; Retrospective cohort study; ERCP PANCREATITIS; RISK-FACTORS; PREVENTION; COMPLICATIONS; INDOMETHACIN; METAANALYSIS; STATINS;
D O I
10.14740/gr1620
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Post-endoscopic retrograde cholangiopancreatogra-phy pancreatitis (PEP) represents the most common serious com-plication after endoscopic retrograde cholangiopancreatography (ERCP). Rectal non-steroidal anti-inflammatory drugs (NSAIDs) and pancreatic duct stenting (PDS) are the prophylactic interven-tions with more evidence and efficacy; however, PEP still represents a significant source of morbidity, mortality, and economic burden. Chronic statin use has been proposed as a prophylactic method that could be cheap and relatively safe. However, the evidence is conflict-ing. We aimed to evaluate the impact of endoscopic and pharmaco-logical interventions including chronic statin and aspirin use, on the development of PEP.Methods: A retrospective cohort study evaluated consecutive patients undergoing ERCP at John H. Stroger, Jr. Hospital of Cook County in Chicago from January 2015 to March 2018. Univariate and multivari-ate analyses were performed using logistic regression.Results: A total of 681 ERCPs were included in the study. Twelve (1.76%) developed PEP. Univariate, multivariate, and subgroup anal-yses did not show any association between chronic statin or aspirin use and PEP. PDS and rectal indomethacin were protective in patients undergoing pancreatic duct injection. Pancreatic duct injection, fe-male sex, and younger age were associated with a higher risk. History of papillotomy was associated with lower risk only in the univariate analysis (all P values < 0.05).Conclusion: Chronic use of statins and aspirin appears to add no ad-ditional benefit to prevent ERCP pancreatitis. Rectal NSAIDs, and PDS after appropriate patient selection continue to be the main pro-phylactic measures. The lower incidence at our center compared with the reported data can be explained by the high rates of rectal indo-methacin and PDS, the use of noninvasive diagnostic modalities for patient selection, and the expertise of the endoscopists.
引用
收藏
页码:149 / 156
页数:8
相关论文
共 50 条
  • [41] Effect of Dexketoprofene Trometamol on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
    Ari, Aziz
    Gurbulak, Bunyamin
    Okmen, Hasan
    Tatar, Cihad
    Idiz, Ufuk Oguz
    Ucuncu, Muhammed Zubeyr
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (06): : 511 - 515
  • [42] Statin consumption and risk of post-endoscopic retrograde cholangiopancreatography pancreatitis
    Martinez-Moneo, Emma
    Cardenas-Jaen, Karina
    Fernandez-Laso, Ana B.
    Millastre-Bocos, Judith
    Torralba-Gallego, Ainara
    Martin-Arriero, Silvia
    Alfaro-Almajano, Enrique
    Garcia-Rayado, Guillermo
    de-Madaria, Enrique
    PANCREATOLOGY, 2020, 20 (05) : 801 - 805
  • [43] Methods for prevention of acute post-endoscopic retrograde cholangiopancreatography pancreatitis
    Jaszczuk, Kamil
    Lipinski, Michal
    Rydzewska, Grazyna
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2020, 15 (02): : 98 - 102
  • [44] Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels
    Lee, Yeon Kyung
    Yang, Min Jae
    Kim, Soon Sun
    Noh, Choong-Kyun
    Cho, Hyo Jung
    Lim, Sun Gyo
    Hwang, Jae Chul
    Yoo, Byung Moo
    Kim, Jin Hong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (11) : 1814 - 1819
  • [45] Hematoma post-endoscopic retrograde cholangiopancreatography
    Ruiz, Sandra Diez
    Cortes, Irene Latras
    Rivas, Sandra Borrego
    Avila, Victor Blazquez
    Palacios, Marcos Jimenez
    Rodriguez, Ruben Diez
    Diez, Jesus Espinel
    Plaza, Francisco Jorquera
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2023, 115 (06) : 347 - +
  • [46] Rectal indomethacin or intravenous gabexate mesylate as prophylaxis for acute pancreatitis post-endoscopic retrograde cholangiopancreatography
    Guglielmi, V.
    Tutino, M.
    Guerra, V.
    Giorgio, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (22) : 5268 - 5274
  • [47] Tacrolimus for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: a potential new target of old drug?
    Jeong, Seok
    CLINICAL ENDOSCOPY, 2022, 55 (05) : 628 - 629
  • [48] A Cost-Effectiveness Analysis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis in the United States
    Thiruvengadam, Nikhil R.
    Saumoy, Monica
    Schneider, Yecheskel
    Attala, Sara
    Triggs, Joseph
    Lee, Peter
    Kochman, Michael L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 216 - +
  • [49] Post-endoscopic retrograde cholangiopancreatography pancreatitis assessed using criteria for acute pancreatitis
    Suzuki, Azumi
    Uno, Koji
    Nakase, Kojiro
    Mandai, Koichiro
    Endoh, Bunji
    Chikugo, Koki
    Kawakami, Takumi
    Suzuki, Takahiro
    Nakai, Yoshitaka
    Kusumoto, Kiyonori
    Itokawa, Yoshio
    Inatomi, Osamu
    Bamba, Shigeki
    Mizumoto, Yoshinori
    Tanaka, Kiyohito
    JGH OPEN, 2021, 5 (12): : 1391 - 1397
  • [50] Pharmacological Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Where Do We Stand Now?
    Ahmad, Wiqas
    Okam, Nkechi A.
    Torrilus, Chenet
    Rana, Dibyata
    Khatun, Mst Khaleda
    Jahan, Nusrat
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)